Intended for healthcare professionals


Australian army faces legal action over mefloquine

BMJ 2004; 329 doi: (Published 04 November 2004) Cite this as: BMJ 2004;329:1062
  1. Bob Burton
  1. Canberra

    The Australian army and Roche Products Australia face a class action after allegations that army personnel had serious side effects after being prescribed mefloquine hydrochloride (Lariam) as part of a research trial for a new anti-malarial drug.

    Since 1998, the Army Malaria Institute, a research organisation of the …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription